アトルバスタチンの世界市場レポート 2025年

アトルバスタチン市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR10.5％で195億7,000万米ドルに成長します。予測期間の成長は、心血管疾患の有病率の増加、高コレステロール値、心臓病に罹患しやすい高齢化人口の増加、コレステロール管理およびスクリーニングプログラムに関する意識の高まり、ジェネリック医薬品としてのアトルバスタチンの競争価格での入手可能性などに起因すると考えられます。予測期間中の主な動向としては、革新的なアトルバスタチン製剤の研究開発への投資、製造におけるグリーンケミストリーの採用、個別化医療や薬理ゲノミクスに基づく治療へのシフト、デジタルヘルス技術の統合、新しいアトルバスタチン製剤などが挙げられます。

心血管疾患の有病率の上昇は、今後数年間のアトルバスタチン市場の成長を促進すると予想されます。心血管疾患（CVD）には、心臓や血管に影響を及ぼすさまざまな障害が含まれます。このような心血管疾患の増加は、ライフスタイルの変化、人口動向、環境要因の混合によるものです。アトルバスタチンは、これらの基礎因子を標的とすることで、心臓発作や脳卒中などの主要な心血管イベントのリスクを大幅に低減する上で重要な役割を果たしています。高コレステロールやその他のCVD危険因子を持つ患者に広く使用され、心血管疾患の全体的な負担軽減に貢献しています。例えば、2024年1月、米国の非営利団体である米国心臓協会（American Heart Association）は、心血管関連の総死亡者数が93万1,578人となり、前年の92万8,741人から3,000人増加したと報告しました。このように、心血管疾患の有病率の上昇がアトルバスタチン市場の成長を促進しています。

アトルバスタチン市場の大手企業は、高コレステロールおよび関連する心血管危険因子の治療を強化するために、既製の液体経口懸濁液などの革新的な製品の開発に注力しています。これらの製剤は、便利で効果的な薬剤投与手段を提供し、特に固形剤の嚥下が困難な患者にとって有益です。例えば、2023年6月、米国の製薬会社CMP Pharma, Inc.は、米国食品医薬品局（FDA）から承認されたAtorvaliq（アトルバスタチンcalcium）経口懸濁液20mg/5mLを発売しました。Atorvaliqは、アトルバスタチンを必要としながらも嚥下障害や嚥下困難に直面している患者に特化した課題です。アトルバリクは、安全で便利なFDA承認の液体製剤であり、ヘルスケア・プロバイダーと対象となる患者に提供されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界アトルバスタチンPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のアトルバスタチン市場：成長率分析
• 世界のアトルバスタチン市場の実績：規模と成長, 2019-2024
• 世界のアトルバスタチン市場の予測：規模と成長, 2024-2029, 2034F
• 世界アトルバスタチン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のアトルバスタチン市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 化学合成
• 生体触媒
• 世界のアトルバスタチン市場治療的治療によって、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心血管疾患
• 肥満
• 炎症性疾患
• その他の治療法
• 世界のアトルバスタチン市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界のアトルバスタチン市場化学合成のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 伝統的な化学合成アトルバスタチン
• 半合成アトルバスタチン生産
• 商業生産のための大規模化学合成
• 世界のアトルバスタチン市場、生体触媒のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 酵素触媒合成アトルバスタチン
• 効率的な生産のための生体触媒経路
• 製造業におけるグリーンケミストリーのアプローチ
• より高い収量と純度のための生体触媒

第7章 地域別・国別分析

• 世界のアトルバスタチン市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のアトルバスタチン市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• アトルバスタチン市場：競合情勢
• アトルバスタチン市場：企業プロファイル
  • Zydus Lifesciences Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Hetero Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Sun Pharmaceutical Industries Ltd.
• Dr. Reddy's Laboratories Ltd.
• Cadila Pharmaceuticals Ltd.
• Apotex Pharmachem Inc.
• Glenmark Pharmaceuticals Ltd.
• Alembic Pharmaceuticals Ltd.
• Centrient Pharmaceuticals
• Accord Healthcare Ltd.
• Wockhardt Ltd.
• Zhejiang Hisun Pharmaceutical Co. Ltd.
• Unichem Laboratories Ltd.
• Morepen
• Ind-Swift Labs Ltd.
• Smilax Laboratories Limited
• Saneca Pharmaceuticals AS

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• アトルバスタチン市場2029：新たな機会を提供する国
• アトルバスタチン市場2029：新たな機会を提供するセグメント
• アトルバスタチン市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Atorvastatin is a statin medication utilized to prevent cardiovascular disease in high-risk individuals and to manage abnormal lipid levels. It plays a crucial role in controlling high cholesterol and reducing the likelihood of cardiovascular diseases, thus serving as a fundamental component in both prevention and treatment of heart disease.

Atorvastatin is produced through two primary methods, chemical synthesis and biocatalysis. Biocatalysis is particularly important in the manufacturing process of atorvastatin, a drug aimed at lowering cholesterol levels. It is employed in diverse therapeutic applications, including cardiovascular disorders, obesity, inflammatory conditions, and others, utilized across various settings such as hospital pharmacies, retail pharmacies, and online pharmacies.

The atorvastatin market research report is one of a series of new reports from The Business Research Company that provides atorvastatin market statistics, including atorvastatin industry global market size, regional shares, competitors with an atorvastatin market share, detailed atorvastatin market segments, market trends, and opportunities, and any further data you may need to thrive in the atorvastatin industry. This atorvastatin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The atorvastatin market size has grown rapidly in recent years. It will grow from $11.86 billion in 2024 to $13.15 billion in 2025 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to increased healthcare expenditure, increased incidence of metabolic disorders and obesity worldwide, sedentary lifestyles and unhealthy dietary habits in many populations, lack of physical activity and exercise, increased focus on preventive healthcare and wellness globally.

The atorvastatin market size is expected to see rapid growth in the next few years. It will grow to $19.57 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to growing prevalence of cardiovascular diseases, high cholesterol levels, increasing aging population more susceptible to heart disease, rising awareness about cholesterol management and screening programs, availability of atorvastatin as a generic drug at competitive prices. Major trends in the forecast period include investments in research and development of innovative atorvastatin formulations, adoption of green chemistry in manufacturing, shift towards personalized medicine and pharmacogenomics-based therapy, integration of digital health technologies, new atorvastatin formulations.

The rising prevalence of cardiovascular diseases is anticipated to drive the growth of the atorvastatin market in the coming years. Cardiovascular diseases (CVDs) include various disorders affecting the heart and blood vessels. This increase in cardiovascular diseases is due to a mix of lifestyle changes, demographic trends, and environmental factors. Atorvastatin plays a key role in significantly reducing the risk of major cardiovascular events like heart attacks and strokes by targeting these underlying factors. Its widespread use among patients with high cholesterol and other CVD risk factors has contributed to lowering the overall burden of cardiovascular diseases. For instance, in January 2024, the American Heart Association, a US-based nonprofit organization, reported a slight increase in total cardiovascular-related deaths, totaling 931,578-up by 3,000 from the previous year's 928,741. Thus, the rising prevalence of cardiovascular diseases is fueling growth in the atorvastatin market.

Leading firms in the atorvastatin market are concentrating on developing innovative products such as ready-made liquid oral suspensions to enhance the treatment of high cholesterol and associated cardiovascular risk factors. These formulations provide a convenient and effective means of administering medications, particularly beneficial for patients who have difficulty swallowing solid dosage forms. For instance, in June 2023, CMP Pharma, Inc., an American pharmaceutical company, introduced Atorvaliq (atorvastatin calcium) Oral Suspension, 20 mg/5 mL, approved by the US Food and Drug Administration (FDA). Atorvaliq caters specifically to patients needing atorvastatin but facing dysphagia or swallowing challenges. Its availability offers healthcare providers and eligible patients a safe, convenient, and FDA-approved liquid option.

In August 2023, Aspen Pharmacare Holdings Limited, a pharmaceutical company based in South Africa, acquired Viatris Inc.'s drug products Portfolio for $280 million. This acquisition was a strategic move by Aspen Pharmacare to expand its Portfolio by integrating Viatris's expertise in offering generic and specialty drugs for treating acute and chronic conditions. Viatris Inc., based in the US, provides various forms of pharmaceuticals including atorvastatin for different cardiovascular-related conditions.

Major companies operating in the atorvastatin market are Zydus Lifesciences, Pfizer Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Hetero Ltd., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cadila Pharmaceuticals Ltd., Apotex Pharmachem Inc., Glenmark Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Centrient Pharmaceuticals, Accord Healthcare Ltd., Wockhardt Ltd., Zhejiang Hisun Pharmaceutical Co. Ltd., Unichem Laboratories Ltd., Morepen, Ind-Swift Labs Ltd., Smilax Laboratories Limited, Saneca Pharmaceuticals AS, Combi-Blocks Inc., Shree HariKrishna Group, Srini Pharmaceuticals Pvt. Ltd., Suvan Lifesciences Ltd., Zenfold Sustainable Technologies

North America was the largest region in the atorvastatin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atorvastatin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the atorvastatin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The atorvastatin market consists of sales of atorvastatin calcium tablets, extended-release tablets, and generic tablets. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Atorvastatin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on atorvastatin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for atorvastatin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The atorvastatin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Chemical Synthesis; Biocatalysis
• 2) By Therapeutic Treatment: Cardiovascular Disorders; Obesity; Inflammatory Disorders; Other Therapeutic Treatments
• 3) By Application: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
• Subsegments:
• 1) By Chemical Synthesis: Traditional Chemical Synthesis Of Atorvastatin; Semi-Synthetic Atorvastatin Production; Large-Scale Chemical Synthesis For Commercial Production
• 2) By Biocatalysis: Enzyme-Catalyzed Synthesis Of Atorvastatin; Biocatalytic Pathways For Efficient Production; Green Chemistry Approaches In Atorvastatin Manufacturing; Biocatalysis For Higher Yield And Purity
• Companies Mentioned: Zydus Lifesciences; Pfizer Inc.; Viatris Inc.; Teva Pharmaceutical Industries Ltd.; Hetero Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Atorvastatin Market Characteristics

3. Atorvastatin Market Trends And Strategies

4. Atorvastatin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Atorvastatin Growth Analysis And Strategic Analysis Framework

• 5.1. Global Atorvastatin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Atorvastatin Market Growth Rate Analysis
• 5.4. Global Atorvastatin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Atorvastatin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Atorvastatin Total Addressable Market (TAM)

6. Atorvastatin Market Segmentation

• 6.1. Global Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemical Synthesis
• Biocatalysis
• 6.2. Global Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiovascular Disorders
• Obesity
• Inflammatory Disorders
• Other Therapeutic Treatments
• 6.3. Global Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• 6.4. Global Atorvastatin Market, Sub-Segmentation Of Chemical Synthesis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Traditional Chemical Synthesis Of Atorvastatin
• Semi-Synthetic Atorvastatin Production
• Large-Scale Chemical Synthesis For Commercial Production
• 6.5. Global Atorvastatin Market, Sub-Segmentation Of Biocatalysis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enzyme-Catalyzed Synthesis Of Atorvastatin
• Biocatalytic Pathways For Efficient Production
• Green Chemistry Approaches In Atorvastatin Manufacturing
• Biocatalysis For Higher Yield And Purity

7. Atorvastatin Market Regional And Country Analysis

• 7.1. Global Atorvastatin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Atorvastatin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Atorvastatin Market

• 8.1. Asia-Pacific Atorvastatin Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Atorvastatin Market

• 9.1. China Atorvastatin Market Overview
• 9.2. China Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Atorvastatin Market

• 10.1. India Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Atorvastatin Market

• 11.1. Japan Atorvastatin Market Overview
• 11.2. Japan Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Atorvastatin Market

• 12.1. Australia Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Atorvastatin Market

• 13.1. Indonesia Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Atorvastatin Market

• 14.1. South Korea Atorvastatin Market Overview
• 14.2. South Korea Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Atorvastatin Market

• 15.1. Western Europe Atorvastatin Market Overview
• 15.2. Western Europe Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Atorvastatin Market

• 16.1. UK Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Atorvastatin Market

• 17.1. Germany Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Atorvastatin Market

• 18.1. France Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Atorvastatin Market

• 19.1. Italy Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Atorvastatin Market

• 20.1. Spain Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Atorvastatin Market

• 21.1. Eastern Europe Atorvastatin Market Overview
• 21.2. Eastern Europe Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Atorvastatin Market

• 22.1. Russia Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Atorvastatin Market

• 23.1. North America Atorvastatin Market Overview
• 23.2. North America Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Atorvastatin Market

• 24.1. USA Atorvastatin Market Overview
• 24.2. USA Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Atorvastatin Market

• 25.1. Canada Atorvastatin Market Overview
• 25.2. Canada Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Atorvastatin Market

• 26.1. South America Atorvastatin Market Overview
• 26.2. South America Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Atorvastatin Market

• 27.1. Brazil Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Atorvastatin Market

• 28.1. Middle East Atorvastatin Market Overview
• 28.2. Middle East Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Atorvastatin Market

• 29.1. Africa Atorvastatin Market Overview
• 29.2. Africa Atorvastatin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Atorvastatin Market, Segmentation By Therapeutic Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Atorvastatin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Atorvastatin Market Competitive Landscape And Company Profiles

• 30.1. Atorvastatin Market Competitive Landscape
• 30.2. Atorvastatin Market Company Profiles
  • 30.2.1. Zydus Lifesciences Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Hetero Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Atorvastatin Market Other Major And Innovative Companies

• 31.1. Sun Pharmaceutical Industries Ltd.
• 31.2. Dr. Reddy's Laboratories Ltd.
• 31.3. Cadila Pharmaceuticals Ltd.
• 31.4. Apotex Pharmachem Inc.
• 31.5. Glenmark Pharmaceuticals Ltd.
• 31.6. Alembic Pharmaceuticals Ltd.
• 31.7. Centrient Pharmaceuticals
• 31.8. Accord Healthcare Ltd.
• 31.9. Wockhardt Ltd.
• 31.10. Zhejiang Hisun Pharmaceutical Co. Ltd.
• 31.11. Unichem Laboratories Ltd.
• 31.12. Morepen
• 31.13. Ind-Swift Labs Ltd.
• 31.14. Smilax Laboratories Limited
• 31.15. Saneca Pharmaceuticals AS

32. Global Atorvastatin Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Atorvastatin Market

34. Recent Developments In The Atorvastatin Market

35. Atorvastatin Market High Potential Countries, Segments and Strategies

• 35.1 Atorvastatin Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Atorvastatin Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Atorvastatin Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer